Drug intelligence / Profile preview

methopterin

Development stage
Unknown
Modality
Small Molecules
Administration
Not Available (investigational Status; No Established Route)
01

Overview

Methopterin is a synthetic folic acid derivative and a structural analog of folic acid. It is classified as an investigational small molecule with effects on osteoclasts. Methopterin inhibits the proliferation and activation of osteoclasts and induces their apoptosis. This action likely contributes to its ability to inhibit inflammatory bone destruction[1][2][4]. It has been studied in the context of bone resorption disorders and has completed Phase 2 clinical trials for hematologic malignancies such as acute biphenotypic leukemia and myelodysplastic syndrome with excess blasts[3]. Chemically it is also known as N10-methylfolic acid or alpha-Methopterin.

Other names
10-methylfolic acid10-methylpteroylglutamic acidalpha-MethopterinMethopterineN10-methylfolic acidN-10-methylfolic acidN 10-methylfolic acidN10-methylpteroylglutamic acidN-10-methylpteroylglutamic acidN 10-methylpteroylglutamic acidMethotrexate related compound CMethotrexate Impurity C

Beyond the preview

Go deeper on methopterin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on methopterin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call